<bill session="116" type="s" number="3855" updated="2020-07-23T05:23:48Z">
  <state datetime="2020-06-01">REFERRED</state>
  <status>
    <introduced datetime="2020-06-01"/>
  </status>
  <introduced datetime="2020-06-01"/>
  <titles>
    <title type="short" as="introduced">CORE Act</title>
    <title type="short" as="introduced">CORE Act</title>
    <title type="short" as="introduced">Coronavirus Oversight and Recovery Ethics Act of 2020</title>
    <title type="short" as="introduced">Coronavirus Oversight and Recovery Ethics Act of 2020</title>
    <title type="display">CORE Act</title>
    <title type="official" as="introduced">A bill to ensure ethical and accountable use of COVID-19 relief funds, to prevent corruption and bias in the disbursement and supervision of those funds, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="W000817"/>
  <cosponsors>
    <cosponsor bioguide_id="B001277" joined="2020-06-01"/>
    <cosponsor bioguide_id="B001288" joined="2020-06-01"/>
    <cosponsor bioguide_id="C001088" joined="2020-06-01"/>
    <cosponsor bioguide_id="D000563" joined="2020-06-01"/>
    <cosponsor bioguide_id="H001075" joined="2020-06-01"/>
    <cosponsor bioguide_id="H001046" joined="2020-06-01"/>
    <cosponsor bioguide_id="H001042" joined="2020-06-01"/>
    <cosponsor bioguide_id="K000384" joined="2020-07-22"/>
    <cosponsor bioguide_id="K000367" joined="2020-06-01"/>
    <cosponsor bioguide_id="M000133" joined="2020-06-01"/>
    <cosponsor bioguide_id="M001176" joined="2020-06-01"/>
    <cosponsor bioguide_id="S000033" joined="2020-06-01"/>
    <cosponsor bioguide_id="U000039" joined="2020-06-01"/>
    <cosponsor bioguide_id="W000779" joined="2020-06-01"/>
  </cosponsors>
  <actions>
    <action datetime="2020-06-01">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-06-01" state="REFERRED">
      <text>Read twice and referred to the Committee on Homeland Security and Governmental Affairs.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSGA" name="Senate Homeland Security and Governmental Affairs" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="identical" number="7076"/>
  </relatedbills>
  <subjects>
    <term name="Government operations and politics"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Advisory bodies"/>
    <term name="Afghanistan"/>
    <term name="Alternative dispute resolution, mediation, arbitration"/>
    <term name="Architect of the Capitol"/>
    <term name="Asia"/>
    <term name="Banking and financial institutions regulation"/>
    <term name="Business expenses"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Central Intelligence Agency (CIA)"/>
    <term name="Civil actions and liability"/>
    <term name="Congressional agencies"/>
    <term name="Congressional operations and organization"/>
    <term name="Congressional oversight"/>
    <term name="Criminal investigation, prosecution, interrogation"/>
    <term name="Department of Labor"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Employment discrimination and employee rights"/>
    <term name="Evidence and witnesses"/>
    <term name="Executive Office of the President"/>
    <term name="Family relationships"/>
    <term name="Federal officials"/>
    <term name="Financial crises and stabilization"/>
    <term name="Fraud offenses and financial crimes"/>
    <term name="Government Accountability Office (GAO)"/>
    <term name="Government Publishing Office (GPO)"/>
    <term name="Government employee pay, benefits, personnel management"/>
    <term name="Government ethics and transparency, public corruption"/>
    <term name="Government information and archives"/>
    <term name="Government lending and loan guarantees"/>
    <term name="Government studies and investigations"/>
    <term name="Health programs administration and funding"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Intelligence activities, surveillance, classified information"/>
    <term name="Judicial review and appeals"/>
    <term name="Law enforcement officers"/>
    <term name="Library of Congress"/>
    <term name="Licensing and registrations"/>
    <term name="Office of Government Ethics"/>
    <term name="Personnel records"/>
    <term name="Presidents and presidential powers, Vice Presidents"/>
    <term name="Public contracts and procurement"/>
    <term name="Public participation and lobbying"/>
    <term name="Reconstruction and stabilization"/>
    <term name="Right of privacy"/>
    <term name="Small business"/>
    <term name="Tax administration and collection, taxpayers"/>
    <term name="U.S. Capitol"/>
    <term name="Wages and earnings"/>
    <term name="Worker safety and health"/>
  </subjects>
  <amendments/>
  <summary date="2020-06-01T04:00:00Z" status="Introduced in Senate">Coronavirus Oversight and Recovery Ethics Act of 2020 or the CORE Act

This bill establishes requirements for oversight, accountability, and transparency in the disbursement and supervision of COVID-19 (i.e., coronavirus disease 2019) relief funds.

Among other things, the bill

 prohibits conflicts of interest in the selection or hiring of contractors or advisors and in the distribution of relief grants and loans; allows inspectors general to be fired only for specified reasons; grants the Congressional Oversight Commission, established in the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), subpoena authority for testimony and documents and expands its jurisdiction to include all COVID-19 relief funding, including the Paycheck Protection Program (PPP) of the Small Business Administration (SBA); requires the Department of the Treasury to submit a weekly list of any instances in which the Special Inspector General for Pandemic Relief or the Pandemic Relief Accountability Committee believe the executive branch has unreasonably denied them information; requires lobbyists to make monthly disclosures regarding all lobbying related to COVID-19 relief spending or lending; establishes whistle-blower protections for government contractors and private sector workers who may witness waste, fraud, or abuse or be victims of misconduct; requires the SBA to publicly disclose information about PPP lenders and recipients, including loan amounts; and allows any individual harmed by a company's misuse of industry stabilization funds to seek recourse through the courts.</summary>
  <committee-reports/>
</bill>
